Request TOC and Sample - Neoantigen Market by Type (Nucleic Acid, Dendritic Acid, Tumor Cell, Synthetic Long Peptide), by Therapeutic Specialty (Gastrointestinal Cancer, Lung Cancer, Solid Tumor, Urinary Systems Cancers, Melanoma, Head and Neck Cancer, Others), by Product (Personalized Neo-Antigen Vaccine, Off-The Shell Neo-Antigen Vaccine), by Cell (Autologous, Allogeneic), by Treatment (Combination Therapy, Mono Therapy), by Technology (Whole Genome Sequencing, RNA Sequencing, HLA Typing), by Route of Administration (Intravenous, Intramuscular, Transdermal, Others) and by Delivery Mechanism (Gene Gun, Electroporation, Liposomes, Virosomes, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Neoantigen Market (2023-2032)

by Type (Nucleic Acid, Dendritic Acid, Tumor Cell, Synthetic Long Peptide), by Therapeutic Specialty (Gastrointestinal Cancer, Lung Cancer, Solid Tumor, Urinary Systems Cancers, Melanoma, Head and Neck Cancer, Others), by Product (Personalized Neo-Antigen Vaccine, Off-The Shell Neo-Antigen Vaccine), by Cell (Autologous, Allogeneic), by Treatment (Combination Therapy, Mono Therapy), by Technology (Whole Genome Sequencing, RNA Sequencing, HLA Typing), by Route of Administration (Intravenous, Intramuscular, Transdermal, Others) and, by Delivery Mechanism (Gene Gun, Electroporation, Liposomes, Virosomes, Others)